Compare QTRX & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | EDAP |
|---|---|---|
| Founded | 2007 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.0M | 128.9M |
| IPO Year | 2017 | 1998 |
| Metric | QTRX | EDAP |
|---|---|---|
| Price | $3.37 | $3.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $6.00 | ★ $10.00 |
| AVG Volume (30 Days) | ★ 877.3K | 23.0K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | $37,632,000.00 | ★ $70,527,000.00 |
| Revenue This Year | $25.49 | N/A |
| Revenue Next Year | $10.04 | $6.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 64.52 | 1.63 |
| 52 Week Low | $2.95 | $1.21 |
| 52 Week High | $8.77 | $5.05 |
| Indicator | QTRX | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 44.04 | 46.20 |
| Support Level | $3.30 | $3.13 |
| Resistance Level | $3.81 | $3.44 |
| Average True Range (ATR) | 0.24 | 0.21 |
| MACD | 0.07 | 0.03 |
| Stochastic Oscillator | 54.25 | 46.57 |
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.